Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
株式のランク #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
株価
$0.12164306
最終同期: 2024-11-11
時価総額
$38.53M
変化(1日)
-4.14%
変化(1年)
0.00%
AU
取引 PharmAust Limited (PAA)

カテゴリー

PharmAust Limited(PAA)の株式分割履歴
PharmAust Limited株(シンボル:PAA)は合計で4回の株式分割を実施しました。
最新の株式分割はFeb 20, 2019に行われました。
Nov 15, 2004より前に購入されたPAA株は、現在0.011443846153846PAA株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
2019-02-20 551:500 x1.102 x0.011443846153846
2016-11-10 27:26 x1.0384615384615 x0.010384615384615
2015-10-30 1:20 x0.05 x0.01
2004-11-15 1:5 x0.2 x0.2
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH